TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15986825

Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Life exhaustion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low index of close relation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low index of social relations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sleep disturbance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stressful events in the family
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stressful events at the job
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High level of hostility
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Negative psychosocial factors (e.g., being a widower, divorced, low education, manual labor, pensioners, low social support)
Number of subjects: 0
Study: 12865375

Group type: EXPERIMENTAL
Intervention: Behavioral training
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Behavioral training plus PFES
Number of subjects: 200

Group type: COMPARATOR
Intervention: Self‐administered behavioral treatment using a self‐help booklet (control condition)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 200
Study: 10369612

Group type: EXPERIMENTAL
Intervention: Fosinopril 10 mg tablet
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: HCTZ 12.5 mg tablet
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Combination tablet of fosinopril 10 mg plus HCTZ 12.5 mg
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Coadministered tablets of fosinopril 10 mg and HCTZ 12.5 mg
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Fosinopril 20 mg tablet
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Combination tablet of fosinopril 20 mg plus HCTZ 12.5 mg
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Coadministered tablets of fosinopril 20 mg and HCTZ 12.5 mg
Number of subjects: 76
Study: 8675554

Group type: EXPERIMENTAL
Intervention: 1.25 mg/day Tibolone
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: 2.5 mg/day Tibolone
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 1839111

Group type: EXPERIMENTAL
Intervention: Catheter interventions (stretching of the stenosis)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Catheter recanalization of the femoral artery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Endogenous risk factors vs smoking
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stenoses of the iliac artery
Number of subjects: 0
Study: 6148621

Group type: EXPERIMENTAL
Intervention: Cimetidine (400-800 mg/day)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Parietal-cell vagotomy (PCV)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Cimetidine or PCV
Number of subjects: 83
Study: 30207041

Group type: EXPERIMENTAL
Intervention: 40-min outdoor time/day
Number of subjects: 6295

Group type: EXPERIMENTAL
Intervention: 80-min outdoor time/day
Number of subjects: 6295

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 6295
Study: 29321687

Group type: EXPERIMENTAL
Intervention: Biofortified maize consumption
Number of subjects: 679
Study: 27463113

Group type: EXPERIMENTAL
Intervention: 3-hour rest after sheath removal
Number of subjects: 730

Group type: COMPARATOR
Intervention: 5-hour rest after sheath removal
Number of subjects: 730
Study: 24549963

Group type: EXPERIMENTAL
Intervention: 200-mg imatinib tablet
Number of subjects: 28

Group type: COMPARATOR
Intervention: 2×100-mg imatinib tablets
Number of subjects: 28
Study: 22371023

Group type: COMPARATOR
Intervention: fs-laser therapy (simulated with modified contact lenses)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Modified lenses with a regular grid pattern
Number of subjects: 27

Group type: COMPARATOR
Intervention: Randomly chosen spacing of laser spots
Number of subjects: 27
Study: 20167668

Group type: EXPERIMENTAL
Intervention: Continued supervised exercise (EX)
Number of subjects: 102

Group type: COMPARATOR
Intervention: No exercise (NoEX)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Weight loss intervention (supervised walking/jogging at 60% Vo(2 max), -400 kcal/session, 5 days/wk, and caloric restriction -600 kcal/day for 4-6 months)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Weight regain (+50% of lost weight for 4-6 months)
Number of subjects: 102
Study: 18391051

Group type: EXPERIMENTAL
Intervention: Standard cognitive-behavioral treatment (CBT)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Group cognitive-behavioral treatment (CBT)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Brief cognitive-behavioral treatment (CBT)
Number of subjects: 100
Study: 16033489

Group type: EXPERIMENTAL
Intervention: Patient safety training intervention (two workshops over a 6-month period)
Number of subjects: 356

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 356
Study: 12447271

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: ERCP
Number of subjects: 0

Group type: COMPARATOR
Intervention: Overall survival, relief of jaundice, technical success, total hospitalization days, or perioperative mortality
Number of subjects: 0
Study: 10069782

Group type: EXPERIMENTAL
Intervention: Oral methionine (L‐methionine 100 mg/kg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Oral methionine preceded by vitamin C (1g/day, for 1 week)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 7745364

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation at 3 Hz
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation at 9 Hz
Number of subjects: 7
Study: 2149673

Group type: EXPERIMENTAL
Intervention: 600 mg of etodolac
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 1,200 mg of etodolac
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: diclofenac
Number of subjects: 36
Study: 6130557

Group type: EXPERIMENTAL
Intervention: Destyrosine-gamma-endorphin (DTGE) high doses (20-120 mg)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 31999876

Group type: EXPERIMENTAL
Intervention: Aquatic resistance training (48 supervised sessions over 4 months)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Usual level of physical activity (Control)
Number of subjects: 87
Study: 30932953

Group type: EXPERIMENTAL
Intervention: Immediate ART arm
Number of subjects: 3438

Group type: COMPARATOR
Intervention: Deferred ART arm
Number of subjects: 3438
Study: 28132876

Group type: EXPERIMENTAL
Intervention: Technology-Enhanced Coaching (TEC)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Peer Coaching alone
Number of subjects: 290

Group type: COMPARATOR
Intervention: Observational Control group
Number of subjects: 290
Study: 25901548

Group type: EXPERIMENTAL
Intervention: Thermal blanket group
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 23313532

Group type: EXPERIMENTAL
Intervention: Usual care plus manual therapy
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Usual care plus exercise therapy
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Usual care plus combined exercise therapy and manual therapy
Number of subjects: 206

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Physical performance tests
Number of subjects: 206
Study: 22108471

Group type: EXPERIMENTAL
Intervention: Viatromb (heparin spraygel 2.400 IU/g)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19728560

Group type: EXPERIMENTAL
Intervention: Test formulation (CYP acetate 2 mg tablet with ethinylestradiol 0.25 mg)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Reference formulation (CYP acetate 2 mg tablet with ethinylestradiol 0.25 mg)
Number of subjects: 44
Study: 17716314

Group type: EXPERIMENTAL
Intervention: Non-surgical (NS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Surgical (SG)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Surgical plus enamel matrix protein derivative (S+EMD)
Number of subjects: 60
Study: 15242562

Group type: EXPERIMENTAL
Intervention: Systemp.desensitizer without acid-etch (group NE)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Systemp.desensitizer with acid-etch (group E)
Number of subjects: 91
Study: 11496446

Group type: EXPERIMENTAL
Intervention: Brief couple therapy intervention (2 to 4 sessions)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 19
Study: 9517520

Group type: EXPERIMENTAL
Intervention: Cisapride (10 mg three times daily for 3 days)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Mental stress (induced by a videogame)
Number of subjects: 19
Study: 8038871

Group type: EXPERIMENTAL
Intervention: Cognitive training combined with phosphatidylserine 2 x 200 mg/day
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Cognitive training combined with pyritinol 2 x 600 mg/day
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Cognitive training twice a week
Number of subjects: 70

Group type: COMPARATOR
Intervention: Social support
Number of subjects: 70
Study: 2690768

Group type: EXPERIMENTAL
Intervention: Danazol (600 mg/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 1206472

Group type: EXPERIMENTAL
Intervention: high-justification-pill
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: no-justification-pill
Number of subjects: 42

Group type: COMPARATOR
Intervention: high-justification-no-pill
Number of subjects: 42

Group type: COMPARATOR
Intervention: no-pill-no-justification
Number of subjects: 42
Study: 30673996

Group type: EXPERIMENTAL
Intervention: Spiritual therapy (12 sessions, 60 minutes each, twice a week)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 24
Study: 29153885

Group type: EXPERIMENTAL
Intervention: Radical Prostatectomy (RP)
Number of subjects: 29147

Group type: EXPERIMENTAL
Intervention: Patients not eligible for the ProtecT trial due to disease aggressiveness
Number of subjects: 29147
Study: 28323200

Group type: EXPERIMENTAL
Intervention: 10 minutes of intense exercise
Number of subjects: 49

Group type: COMPARATOR
Intervention: Easy walking
Number of subjects: 49
Study: 26468453

Group type: EXPERIMENTAL
Intervention: Selenomethionine (SLM) 3600 μg/m(2) twice daily for 7 days prior to CRT, once daily during CRT, and daily for 3 weeks following CRT
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Selenomethionine (SLM)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (CRT with cisplatin)
Number of subjects: 18
Study: 23554139

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: PFMT with deep abdominal muscle training (PFMT + TrA)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Combined treatment groups (PFMT and PFMT + TrA)
Number of subjects: 57
Study: 21146358

Group type: EXPERIMENTAL
Intervention: Retrieval cues presented during exposure in Study 2
Number of subjects: 90

Group type: COMPARATOR
Intervention: No cues presented during exposure in Study 2
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Cues presented during exposure in Study 3
Number of subjects: 90

Group type: COMPARATOR
Intervention: No cues presented during exposure in Study 3
Number of subjects: 90
Study: 18646366

Group type: EXPERIMENTAL
Intervention: Silica whitening toothpaste containing blue covarine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clear gel negative control toothpaste
Number of subjects: 0
Study: 17441971

Group type: EXPERIMENTAL
Intervention: Topiramate (mean modal dose ± SD = 100 ± 17 mg/day)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 59
Study: 15479128

Group type: EXPERIMENTAL
Intervention: Leptin concentration in subcutaneous fat tissue
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TNFalpha concentration in subcutaneous fat tissue
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TNFalpha concentration in visceral fat tissue
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Correlation between BMI and leptin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Correlation between BMI and TNFalpha
Number of subjects: 0
Study: 11398153

Group type: EXPERIMENTAL
Intervention: Ciprofibrate 100 mg/d
Number of subjects: 68

Group type: COMPARATOR
Intervention: Gemfibrozil 1,200 mg/d
Number of subjects: 68
Study: 9514471

Group type: EXPERIMENTAL
Intervention: Acoustic stethoscopes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Electronic stethoscopes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New electronic stethoscope design
Number of subjects: 0
Study: 7836516

Group type: EXPERIMENTAL
Intervention: Fertility drugs
Number of subjects: 1534

Group type: COMPARATOR
Intervention: Control group (no fertility drugs)
Number of subjects: 1534
Study: 3400659

Group type: EXPERIMENTAL
Intervention: Estrogen treatment for 2 years
Number of subjects: 153

Group type: COMPARATOR
Intervention: Placebo treatment for 2 years
Number of subjects: 153
Study: 28643425

Group type: EXPERIMENTAL
Intervention: Insulin degludec/liraglutide (IDegLira)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin glargine U100 (IGlar)
Number of subjects: 0
Study: 27228299

Group type: EXPERIMENTAL
Intervention: Pazopanib or Sunitinib
Number of subjects: 1392
Study: 24943725

Group type: EXPERIMENTAL
Intervention: Deep-sequencing (DS) analysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Population sequencing (PS)
Number of subjects: 0
Study: 22260736

Group type: EXPERIMENTAL
Intervention: SMS based intervention for smoking cessation (2 text messages promoting smoking cessation per week for 3 months)
Number of subjects: 910

Group type: COMPARATOR
Intervention: Assessment only control group
Number of subjects: 910
Study: 20511192

Group type: EXPERIMENTAL
Intervention: CED of cintredekin besudotox (CB) at 0.5 microg/mL administered over 96 hours via 2-4 intraparenchymal catheters after tumor resection
Number of subjects: 296

Group type: COMPARATOR
Intervention: Gliadel wafers (GW) at 3.85%/7.7 mg carmustine per wafer, maximum 8 wafers placed immediately after tumor resection
Number of subjects: 296
Study: 18455389

Group type: EXPERIMENTAL
Intervention: Protein ingestion (15 g whey)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Resistance exercise (5 sets of 10 repetition maximums)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Immunohistochemical staining
Number of subjects: 18
Study: 15786818

Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 9297

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9297
Study: 11837570

Group type: EXPERIMENTAL
Intervention: Antibacterial eradication therapy
Number of subjects: 198
Study: 10613232

Group type: EXPERIMENTAL
Intervention: Castor oil
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ultrasound gel
Number of subjects: 60

Group type: COMPARATOR
Intervention: Vaseline
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (Ultrasound gel and Vaseline)
Number of subjects: 60
Study: 8573412

Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg/day
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Alendronate 20 mg/day
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Intranasal salmon calcitonin 100 IU/day
Number of subjects: 286

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 286
Study: 1902992

Group type: EXPERIMENTAL
Intervention: Ampicillin, Gentamicin and Clindamycin (AGC)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Cefotaxime and Clindamycin (CC)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Both AGC and CC
Number of subjects: 97
Study: 6771815

Group type: EXPERIMENTAL
Intervention: 0.85 g alcohol/kg body weight
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.63 g alcohol/kg body weight
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.41 g alcohol/kg body weight
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Frequent consumers of alcohol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rare consumers of alcohol
Number of subjects: 0
Study: 31731176

Group type: EXPERIMENTAL
Intervention: RCTs that reported sample size methodology
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: RCTs that specified levels of significance (α), powers, tails of the test, and effect size
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: RCTs that provided all necessary parameters to compute sample sizes
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: RCTs with effect size information
Number of subjects: 223
Study: 30602156

Group type: EXPERIMENTAL
Intervention: Mixed online Haemodiafiltration (Mixed OL-HDF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Post-dilution OL-HDF
Number of subjects: 0

Group type: COMPARATOR
Intervention: Online high-efficiency haemodialysis (OL-HEH)
Number of subjects: 0
Study: 28157725

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Person-Centered Therapy (PCT)
Number of subjects: 71
Study: 26445425

Group type: EXPERIMENTAL
Intervention: Closed reduction and percutaneous cannulated screw fixation (CRCF)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Open reduction and tension band wiring fixation (ORTF)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: CRCF
Number of subjects: 63

Group type: COMPARATOR
Intervention: ORTF
Number of subjects: 63
Study: 23981368

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (10 sessions over 3 months)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control group (no placebo treatment)
Number of subjects: 122
Study: 21255422

Group type: EXPERIMENTAL
Intervention: GLP-1 (1.2 pmol/kg/minute)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 19829199

Group type: EXPERIMENTAL
Intervention: Women's crisis houses
Number of subjects: 103

Group type: COMPARATOR
Intervention: Psychiatric wards
Number of subjects: 103
Study: 17635487

Group type: EXPERIMENTAL
Intervention: Antimicrobial vaginal pessary containing tetracycline and amphotericin B, administered twice a day for 14 days after LLETZ
Number of subjects: 321

Group type: COMPARATOR
Intervention: No medication (control group)
Number of subjects: 321
Study: 16013901

Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors (fluoxetine [N = 42] and paroxetine [N = 43])
Number of subjects: 85
Study: 12542933

Group type: EXPERIMENTAL
Intervention: Electronic monitoring caps
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Patient medication diaries
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Self-report
Number of subjects: 180

Group type: COMPARATOR
Intervention: No surveillance control group
Number of subjects: 180
Study: 9660442

Group type: EXPERIMENTAL
Intervention: Low-technology monitoring (BBT charts)
Number of subjects: 45

Group type: COMPARATOR
Intervention: High-technology monitoring (BBT charts, urinary LH kits, vaginal ultrasound)
Number of subjects: 45
Study: 7648717

Group type: EXPERIMENTAL
Intervention: IgM-enriched IVIG (250 mg/kg per day for 4 days)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Standard IVIG (250 mg/kg per day for 4 days)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control (no IVIG, supportive and antibiotic therapy)
Number of subjects: 130
Study: 2667612

Group type: EXPERIMENTAL
Intervention: Topical 1 alpha,25-dihydroxyvitamin D3 (0.5 microgram applied twice daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 0
Study: 345313

Group type: EXPERIMENTAL
Intervention: Oral pimozide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Depot injections of fluphenazine decanoate
Number of subjects: 0
Study: 31303099

Group type: EXPERIMENTAL
Intervention: Tidal peritoneal dialysis
Number of subjects: 88

Group type: COMPARATOR
Intervention: Ultrafiltration therapy
Number of subjects: 88
Study: 27546708

Group type: EXPERIMENTAL
Intervention: Subcutaneous immunoglobulin therapy
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 23
Study: 28003302

Group type: EXPERIMENTAL
Intervention: Early Surgery
Number of subjects: 402

Group type: COMPARATOR
Intervention: Conservative Treatment
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analysis
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Secondary outcomes
Number of subjects: 402
Study: 25216771

Group type: EXPERIMENTAL
Intervention: Umezu polyphenols (UP) 800 mg daily for 12 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo 0 mg daily for 12 weeks
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Umezu polyphenols (UP)
Number of subjects: 15
Study: 22027703

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (D₃), 300,000 IU
Number of subjects: 36

Group type: COMPARATOR
Intervention: Ergocalciferol (D₂), 300,000 IU
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (D₃)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Ergocalciferol (D₂)
Number of subjects: 36
Study: 19531171

Group type: EXPERIMENTAL
Intervention: Coblator dissection
Number of subjects: 70

Group type: COMPARATOR
Intervention: Cold steel dissection
Number of subjects: 70
Study: 17911080

Group type: EXPERIMENTAL
Intervention: Aprotinin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Retrograde and antegrade perfusion
Number of subjects: 12
Study: 15266334

Group type: COMPARATOR
Intervention: Gemcitabine (GEM) 1200 mg m(‐2) on days 1, 8 and 15 every 28 days
Number of subjects: 264

Group type: COMPARATOR
Intervention: Paclitaxel (PTX) 100 mg m(‐2) on days 1, 8 and 15 every 28 days
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Gemcitabine (GEM) 1000 mg m(‐2) plus Paclitaxel (PTX) 80 mg m(‐2) (GT) on days 1 and 8 every 21 days
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Gemcitabine (GEM) 1000 mg m(‐2) plus Vinorelbine (VNR) 25 mg m(‐2) (GV) on days 1 and 8 every 21 days
Number of subjects: 264
Study: 11555525

Group type: EXPERIMENTAL
Intervention: CPAP treatment
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo CPAP treatment
Number of subjects: 38